2McMurray JJ, Stewart S. Heart failure : epidemiology, aetiology, and prognosis of heart failure. Heart, 2000, 83:596-602.
3Eiehhorn EJ. Prognosis determination in heart failure. Am J Med, 2001,110(Suppl) : 14-35.
4Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines ( Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death ): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation, 2006, 114 : e385-e484.
5Aaronson KD, Schwartz JS, Chen TM, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation, 1997, 95:2660-2667.
6Green P, Lund LH, Mancini D. Comparison of peak exercise oxygen consumption and the Heart Failure Survival Score for predicting prognosis in women versus men. Am J Cardiol, 2007, 99 : 399 -403.
7Fonarow GC, Adams KF, Abraham WT, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA, 2005, 293: 572-580.
8Frankel DS, Piette JD, Jessup M, et al. Validation of prognostic models among patients with advanced heart failure. J Card Fail, 2006, 12:430-435.
9Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation, 2006. 113 : 1424-1433.
10May HT, Home BD, Levy WC, et al. Validation of the Seattle Heart Failure Model in a Community-Based Heart Failure Population and Enhancement by Adding B-Type Natriuretie Peptide. Am J Cardiol, 2007, 100:697-700.
